1. Targeting Cancer Metabolism to Resensitize Chemotherapy: Potential Development of Cancer Chemosensitizers from Traditional Chinese Medicines
   null Guo et al, 2020, Cancers CrossRef
2. MAZ51 Blocks the Tumor Growth of Prostate Cancer by Inhibiting Vascular Endothelial Growth Factor Receptor 3
   Aya Yamamura et al, 2021, Front. Pharmacol. CrossRef
3. Combination of Metformin, Sodium Oxamate and Doxorubicin Induces Apoptosis and Autophagy in Colorectal Cancer Cells via Downregulation HIF-1α
   Jossimar Coronel-Hernández et al, 2021, Front. Oncol. CrossRef
4. A proteomic atlas of ligand-receptor interactions at the ovine maternal-fetal interface reveals the role of histone lactylation in uterine remodeling.
   Qianying Yang et al, 2022, J Biol Chem CrossRef
5. Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?
   Yong Weon Yi et al, 2021, IJMS CrossRef
6. Exploring the Role of Metabolites in Cancer and the Associated Nerve Crosstalk
   Inah Gu et al, 2022, Nutrients CrossRef
7. Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies.
   Yi Zhang et al, 2022, Cancers (Basel) CrossRef
8. Inhibition of O-GlcNAc transferase sensitizes prostate cancer cells to docetaxel
   Mingyue Xia et al, 2022, Front. Oncol. CrossRef
9. New horizons in modulating the radio-sensitivity of head and neck cancer - 100 years after Warburg’ effect discovery
   Camil Ciprian Mireștean et al, 2022, Front. Oncol. CrossRef
10. Adrenomedullin induces cisplatin chemoresistance in ovarian cancer through reprogramming of glucose metabolism
    Lei Dou et al, 2023 CrossRef
11. FOXP3 targets KIF5A to increase lactate production and promote docetaxel resistance in lung adenocarcinoma
    Liangliang Dong et al, 2024, ABBS CrossRef